What is Kuangli Bio-Tech Holdings Co Days Payable?
Kuangli Bio-Tech Holdings CoTPE:6431 -1.92%69 Days Payable is 48.97 as of Dec. 2025, which is 10% below its 10-year median of 54.46. GuruFocus rates TPE:6431 with a GF Score™ of 69/100 and a GF Value™ of NT$11.72 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,881 Consumer Packaged Goods companies, Kuangli Bio-Tech Holdings Co ranks better than 65.98% on this metric.
The historical rank and industry rank for Kuangli Bio-Tech Holdings Co's Days Payable or its related term are showing as below:
TPE:6431'
s Days Payable Range Over the Past 10 Years
Min: 13.68 Med: 54.46 Max: 379.39
Current: 60.93
During the past 13 years, Kuangli Bio-Tech Holdings Co's highest Days Payable was 379.39. The lowest was 13.68. And the median was 54.46.
TPE:6431's Days Payable is ranked better than 65.98% of 1881
companies
in the Consumer Packaged Goods industry
Industry Median: 44.14
vs TPE:6431: 60.93
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Kuangli Bio-Tech Holdings Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kuangli Bio-Tech Holdings Co Days Payable vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Kuangli Bio-Tech Holdings Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Kuangli Bio-Tech Holdings Co's Days Payable falls into.
Kuangli Bio-Tech Holdings Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kuangli Bio-Tech Holdings Co (TPE:6431) has a Days Payable of 48.97 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kuangli Bio-Tech Holdings Co and its competitors. This is 10% below median its historical median of 54.46. Over the past decade, Kuangli Bio-Tech Holdings Co's Days Payable has ranged from 13.68 to 379.39. According to the industry distribution chart, Kuangli Bio-Tech Holdings Co ranks #640 out of 1881 companies in the Consumer Packaged Goods industry, placing it in the top 34%.
Is Kuangli Bio-Tech Holdings Co's Days Payable too high?
Kuangli Bio-Tech Holdings Co's current Days Payable of 48.97 is 10% below median its 10-year median of 54.46. Over the past 10 years, this metric has ranged from a low of 13.68 to a high of 379.39. The Consumer Packaged Goods industry median Days Payable is 44.14. Kuangli Bio-Tech Holdings Co's value of 48.97 is 10.9% above this industry median. Based on the distribution chart, Kuangli Bio-Tech Holdings Co ranks #640 out of 1881 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Kuangli Bio-Tech Holdings Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kuangli Bio-Tech Holdings Co's Days Payable compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Kuangli Bio-Tech Holdings Co ranks #640 out of 1881 companies for Days Payable. This puts Kuangli Bio-Tech Holdings Co in the upper half of its industry. The industry median Days Payable is 44.14. Kuangli Bio-Tech Holdings Co's value of 48.97 is 10.9% above this benchmark. Historically, Kuangli Bio-Tech Holdings Co's own Days Payable has ranged from 13.68 to 379.39 over the past decade. While the company's 10-year median is 54.46 vs. the industry median of 44.14, Kuangli Bio-Tech Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Consumer Packaged Goods company?
The median Days Payable among Consumer Packaged Goods companies is 44.14, based on 1,881 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kuangli Bio-Tech Holdings Co's current Days Payable of 48.97 is 10.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Kuangli Bio-Tech Holdings Co and its competitors. For the Consumer Packaged Goods industry, the median Days Payable is 44.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kuangli Bio-Tech Holdings Co's current Days Payable is 48.97, which is 10% below median its own 10-year median of 54.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kuangli Bio-Tech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co (TPE:6431) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$11.72, compared to a current price of NT$17.85 — trading 52.3% above its estimated fair value. The current Days Payable is 48.97, which is 10% below median its 10-year median of 54.46 and 10.9% above the Consumer Packaged Goods industry median of 44.14. Kuangli Bio-Tech Holdings Co's overall GF Score™ is 69/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Kuangli Bio-Tech Holdings Co (TPE:6431), the current Days Payable is 48.97 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kuangli Bio-Tech Holdings Co (TPE:6431) Overvalued in 2026?
Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co stock appears to be overvalued.
The current stock price of NT$17.85 is trading 52.3% above its estimated GF Value™ of NT$11.72.
GuruFocus considers Kuangli Bio-Tech Holdings Co to be Significantly Overvalued.
Key valuation signals for TPE:6431:
Days Payable: 48.97 (10% below median its 10-year median of 54.46)
GF Value™: NT$11.72 vs. price of NT$17.85 (52.3% above fair value)
Industry Position: 10.9% above the Consumer Packaged Goods median (#640 of 1881)
No single metric tells the full story. See the TPE:6431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kuangli Bio-Tech Holdings Co Ltd is mainly engaged in the manufacture and trading of various types of panels (LENS), such as mobile phone panels, digital camera windows, PDA panels, and instrument panels. The company is also engaged in the development, manufacturing and trading of cosmetics and skin care products and other related biotechnology products. It derives revenue from Health and Wellness products, and Cosmetics and skin care products, including Lotion, Facial masks, and Other pastes. The primary source of revenue for the company is sales of cosmetic products.
69GF Score
Get the complete analysis for TPE:6431
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6431 has been successfully added to your 
